Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Test results

19 May 2009 08:00

RNS Number : 4559S
Plant Health Care PLC
19 May 2009
 



19 May 2009

Plant Health Care plc 

("Plant Health Care" or "the Company")

The Journal of the American Society of Horticultural Science recently published the findings of an extensive testing and research progamme carried out on Plant Health Care's harpin product when used with lettuce (J. AMER. SOC. HORT. SCI. 134(1):141-147. 2009.). 

A summary of the findings is set out below.


 

 

Researchers from three US academic institutions (Rutgers University, University of California, Davis and University of Arizona), led by Dr. Jorge M. Fonseca at the University of Arizona's Yuma Agricultural Center, have investigated the effect of a pre-harvest treatment of head lettuce with Plant Health Care's harpin protein which is known to boost plants' growth processes and resistance to disease.

Lettuce plants grown at the three locations were treated, five days before harvest with three different rates of the harpin A/B second generation protein. After processing and bagging the lettuces were cool-stored and their quality evaluated over a period of 20 days.

At the two higher rates, the harpin-treated lettuce from California consistently showed better visual quality and lower microbial population than the control. Similarly in Arizona, for part of the storage period, microbial population was lower and visual quality was higher in lettuce treated with harpin at the two higher rates. Overall results in New Jersey showed no major differences among treatments. 

In additional experiments it was shown that antioxidants increased by 40% in head leaves when plants were treated with the two higher rates of harpin, but no visible changes were observed in outer leaves. Furthermore, phenolic content was higher in all treated lettuce than in the control lettuce after 24 hours. Six days later, the levels fell back to the initial stage. 

Overall, it was shown that a pre-harvest, field application of harpin can improve quality of fresh-cut head lettuce under certain environmental conditions. The results with antioxidant activity and phenolic content suggest that improvement in quality is probably the result of alteration of metabolites' composition.

The study clearly shows the potential for harpin use as a pre-harvest treatment to improve several important health and appearance-related aspects of this important produce crop.

- ends -

Enquiries:

Plant Health Care plc

John Brady, Chief Executive Officer

Tel: +1-603-525-3702

jabrady@planthealthcare.com

Evolution Securities

Tavistock Communications 

Tim Worlledge / Tim Redfern

Jeremy Carey/Matt Ridsdale

Tel: +44-20-7071-4300 

Tel: +44-20-7920-3150

tim.worlledge@evosecuties.com

tim.redfern@evosecuties.com

jcarey@tavistock.co.uk

mridsdale@tavistock.co.uk

About Plant Health Care plc:

Plant Health Care plc is a leading provider of natural products for plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, Plant Health Care currently has approximately 90 employees and has operations in the United States, Mexico, the United Kingdom, Spain, and the Netherlands. The Company listed on the AIM market of the London Stock Exchange in July 2004. Ticker symbol is PHC.

Plant Health Care's products are aimed at the agriculture and landscape industries and are environmentally beneficial. Through the commercialisation of these products, Plant Health Care is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. Further information is available at: www.planthealthcare.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAKSPFLLNEFE
Date   Source Headline
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:36 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSTrading Statement
11th Jan 20217:00 amRNSNotice of Trading Statement/Investor Presentation
5th Jan 20213:37 pmRNSBrazil approves PHC279 to Control Soybean Rust
11th Dec 20207:00 amRNSInvestor Presentation
9th Nov 20207:00 amRNSPlant Health Care and Wilbur-Ellis sign Agreement
7th Oct 20207:00 amRNSGrant of Options
6th Oct 20207:00 amRNSNew US PREtec Patents Issued
2nd Oct 20205:48 pmRNSSignificant Shareholder
25th Sep 20207:00 amRNSInvestor Presentation
23rd Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSInterim Report 30 June 2020
29th Jul 20207:00 amRNSTrading Statement
26th Jun 20204:41 pmRNSSecond Price Monitoring Extn
26th Jun 20204:36 pmRNSPrice Monitoring Extension
25th Jun 20207:00 amRNSGrant of Options
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSPHC398 Approved by US EPA: PHC279 submitted to EPA
9th Jun 20207:00 amRNSGrant of options
2nd Jun 202011:13 amRNSResult of AGM
29th May 20207:00 amRNSHolding(s) in Company
27th May 20207:00 amRNSUpdate on PHC279 2019 Field Trials
6th May 20205:12 pmRNSAnnual Report & Accounts and AGM Notice Published
1st May 20203:21 pmRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSResults for the year ended 31 December 2019
25th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20203:45 pmRNSHolding(s) in Company
19th Mar 20203:09 pmRNSHolding(s) in Company
16th Mar 202011:53 amRNSResults of General Meeting
11th Mar 20207:00 amRNSPHC279 Submitted for Regulatory Approval in Brazil
24th Feb 20209:18 amRNSResults of Placing and Subscription
24th Feb 20207:00 amRNSProposed Placing and Subscription
19th Feb 20207:00 amRNSBlock listing Interim Review
5th Feb 20207:00 amRNSEmploy California Registration
23rd Jan 20207:00 amRNSFirst US patent issues for PREtec peptide products
9th Jan 20207:00 amRNSBrazil Update
20th Dec 20197:00 amRNSHolding(s) in Company
19th Dec 20197:00 amRNSTrading Update
3rd Dec 20196:35 pmRNSHolding(s) in Company
22nd Nov 20192:11 pmRNSHolding(s) in Company
15th Nov 20193:42 pmRNSHolding(s) in Company
15th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSHolding(s) in Company
13th Nov 20194:40 pmRNSHolding(s) in Company
13th Nov 20194:08 pmRNSHolding(s) in Company
13th Nov 20193:59 pmRNSHolding(s) in Company
13th Nov 20193:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.